Optibrium™, a developer of software for drug discovery, has entered a collaboration with MSD tradename of Merck & Co., Inc, Kenilworth NJ USA.
As part of the collaboration MSD has adopted Optibrium’s StarDrop™ software as a central component of their cheminformatics infrastructure.
The collaboration, between MSD and Optibrium will include integration of StarDrop with MSD’s in-house capabilities and the joint development of new tools, to improve cycle times, efficiency and productivity of the drug discovery process.
Dr Matthew Segall, Optibrium’s CEO, said: “We are delighted to enter this collaboration to contribute to MSD’s world-leading cheminformatics infrastructure. We look forward to working together to advance new tools based around StarDrop to further refine our compound design platform.”